Catalyst Wire Dossier Catalyst Wire Dossier

dihydroartemisinin + piperaquine tetraphosphate

dihydroartemisinin + piperaquine tetraphosphate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dihydroartemisinin + piperaquine tetraphosphate, covering 2017-07-13 to 2017-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate [Phase 1]

See pricing